Vitreous Hemorrhage

04/01/2012 - "Preoperative use of bevacizumab improved the 6-month visual outcome in patients undergoing PPV for PDR and significantly reduced the occurrence of postoperative vitreous hemorrhage."
08/31/2017 - "The results suggested that the use of intravitreal bevacizumab was effective in reducing early postoperative vitreous hemorrhage (i.e. "
10/01/2016 - "The Efficacy of Intravitreal Bevacizumab in Vitreous Hemorrhage of Diabetic Subjects."
01/01/2013 - "Intravitreal bevacizumab reduced the height of the pigment epithelial detachment and cleared vitreous hemorrhage. "
11/01/2021 - "Commentary: Outcomes of preoperative bevacizumab in diabetics with nonclearing vitreous hemorrhage without tractional detachment - A quasi-randomized retrospective study."

01/01/2011 - "The purpose of this study was to report a patient with familial retinal arteriolar tortuosity who presented with both retinal and vitreous hemorrhages. "
09/01/2023 - "The disease commonly manifests as peripheral retinal perivasculitis, peripheral retinal capillary nonperfusion, neovascularization, and recurrent vitreous hemorrhage. "
09/01/2023 - "A fundus examination showed dilated, tortuous veins; dot-blot and flame hemorrhaging; numerous cotton-wool spots; and polygonal areas of retinal whitening consistent with Purtscher flecken in the right eye and a vitreous hemorrhage in the left eye. "
07/01/2023 - "Secondary retinal features included intra/subretinal exudation (n = 41, 82%), vascularity (n = 32, 64%), subretinal fluid (n = 21, 42%), retinal neovascularisation (n = 9, 18%) and vitreous hemorrhage (n = 8, 16%). "
06/01/2023 - "AN 82-YEAR-OLD WOMAN WITH RETINAL VASCULAR SHEATHING AND VITREOUS HEMORRHAGE."

08/05/2015 - "The aim of this study was to investigate the effects of ranibizumab plus combined surgery for NVG with vitreous hemorrhage. "
01/01/2022 - "The Port Delivery System with ranibizumab-journey of mitigating vitreous hemorrhage."
10/01/2020 - "The "combination" group had better control of neovascularization and less events of vitreous hemorrhage than ranibizumab alone through the 2 years. "
08/01/2020 - "To develop an animal model of vitreous hemorrhage (VH) to explore the impact of surgical parameters on VH associated with insertion of the Port Delivery System with ranibizumab (PDS) implant. "
08/01/2020 - "EVALUATION OF SURGICAL FACTORS AFFECTING VITREOUS HEMORRHAGE FOLLOWING PORT DELIVERY SYSTEM WITH RANIBIZUMAB IMPLANT INSERTION IN A MINIPIG MODEL."

01/01/2020 - "Intravitreal ziv-aflibercept in diabetic vitreous hemorrhage."
07/01/2021 - "In the full cohort, the median time to clearance of the initial vitreous hemorrhage was 36 (interquartile range [IQR], 24-52) weeks in the aflibercept group vs 4 (IQR, 4-4) weeks in the vitrectomy group (difference, 32 [95% CI, 20-32] weeks; P < .001). "
01/01/2023 - "Determining the Superiority of Vitrectomy vs Aflibercept for Treating Dense Diabetic Vitreous Hemorrhage: A Systematic Review and Meta-Analysis of Randomized Clinical Trials."
12/03/2021 - "A 25-year-old female with bilateral PDR and vitreous hemorrhage received 2 monthly intravitreal injections of aflibercept in both eyes. "
09/04/2021 - "Postoperative corrected visual acuity in the left eye was 20/20, and aflibercept intravitreal injection was performed for prevention of recurrence of vitreous hemorrhage. "

03/01/2011 - "Intravitreal ovine hyaluronidase injection was effective in clearing vitreous hemorrhage. "
10/01/2005 - "To evaluate the efficacy of intravitreous ovine hyaluronidase for the management of vitreous hemorrhage. "
10/01/2005 - "Subjects with vitreous hemorrhage > or = 1 month, severe at entry and best corrected visual acuity (BCVA) worse than 20/200 in the study eye were randomized to 7.5 IU, 55 IU, 75 IU ovine hyaluronidase, saline, or no injection. "
10/01/2005 - "Safety results of two phase III trials of an intravitreous injection of highly purified ovine hyaluronidase (Vitrase) for the management of vitreous hemorrhage."
10/01/2005 - "Pooled efficacy results from two multinational randomized controlled clinical trials of a single intravitreous injection of highly purified ovine hyaluronidase (Vitrase) for the management of vitreous hemorrhage."

12/01/2007 - "To evaluate the efficacy of intravitreal triamcinolone acetonide (IVT) for the management of postvitrectomy diabetic vitreous hemorrhage. "
12/01/2007 - "Efficacy of intravitreal triamcinolone acetonide for eyes with postvitrectomy diabetic vitreous hemorrhage."
09/01/2006 - "Intravitreal triamcinolone acetonide in eyes with recurrent postvitrectomy diabetic vitreous hemorrhage."
09/01/2006 - "To evaluate the efficacy of intravitreal triamcinolone acetonide (IVT) for the management of recurrent post-vitrectomy diabetic vitreous hemorrhage (VH). "
10/01/2008 - "Intravitreal triamcinolone acetonide injection at the end of vitrectomy for diabetic vitreous hemorrhage: a randomized, clinical trial."

11/01/2013 - "Natural evolution of experimental vitreous hemorrhage and effects of corticosteroids on its course."
10/01/1974 - "[Effect of laser coagulation, corticosteroids and cryoapplication of the sclera on resorption of vitreous hemorrhages]."
12/01/1986 - "Laser photocoagulation appears effective in preventing vitreous hemorrhage in these patients, but systemic administration of corticosteroids did not cause the new vessels to regress."
11/01/1995 - "Although treatment with laser therapy and corticosteroids was initiated, the patient developed recurrent vitreous hemorrhages that required pars plana vitrectomy. "
01/01/2017 - "We report a case of CRVO due to TB-associated uveitis, which initially remitted by repeated IVR as an adjunct to anti-TB therapy and systemic corticosteroids, but subsequently led to severe vitreous hemorrhage (VH). "

12/01/2021 - "Conclusion: In patients with PCV and vitreous hemorrhage, compared with postoperative anti-VEGF, perioperative anti-VEGF could reduce the difficulty of surgery and reduce the occurrence of postoperative complications, but there were no differences in long-term vision and macular thickness after surgery."
03/01/2019 - "Levels of vitreous VEGF at the time of PPV were significantly higher in eyes with: vitreous hemorrhage on the first day after PPV (p = 0.003); FVP on the first day and 12 months after PPV (p = 0.002 and p < 0.001, respectively); iris rubeosis on the first day and 12 months after PPV surgery (p < 0.001, and p = 0.001, respectively); NVG on the first day and 12 months after PPV surgery (p = 0.043 and p = 0.011, respectively), compared to the eyes without complications. "
01/01/2019 - "Both the absolute value of postoperative VEGF concentrations and the postop/baseline VEGF ratios declined with time and dramatically decreased in groups 3 and 4. In only two eyes, the postoperative VEGF level was even higher than the baseline VEGF level (postop/baseline VEGF ratio >1), and recurrent vitreous hemorrhage developed within six months in these two eyes. "
01/01/2015 - "Adjunctive anti-VEGF could be considered in managing neovascularization secondary to RVO in cases of vitreous hemorrhage. "
12/01/2011 - "Although vascular endothelial growth factor (VEGF) is abundant in serum, the intraocular concentration of VEGF in eyes with massive vitreous hemorrhage (VH) is not well-known. "

03/01/1995 - "Repetitive, low-dose tissue plasminogen activator for clearance of experimental vitreous hemorrhage."
12/01/1994 - "Repetitive low-dose tissue plasminogen activator for the clearance of experimental vitreous hemorrhage."
08/01/2001 - "Management of postvitrectomy diabetic vitreous hemorrhage with tissue plasminogen activator (t-PA) and volume homeostatic fluid-fluid exchanger."
06/01/1990 - "Treatment of experimental vitreous hemorrhage with tissue plasminogen activator."
06/01/1989 - "Intravitreal tissue plasminogen activator treatment of experimental vitreous hemorrhage."

01/01/2023 - "In addition, postoperative ERM was significantly associated with a larger area of peripheral pathology (P = 0.012), a larger extent of RRD (P = 0.013), vitreous hemorrhage (P = 0.026), redetachment within 6 months (P = 0.022), use of silicone oil as a tamponade (P = 0.047), and number of surgeries within 6 months (P = 0.027). "
01/01/2022 - "Baseline visual acuity, duration of diabetes treatment, tractional membrane, silicone oil tamponade, smoking, and vitreous hemorrhage correlated with logMAR VA at 1 year (r = 0.450, -0.159, 0.221, 0.280, 0.067, and -0.105; all P ≤ 0.036). "
09/01/2020 - "The vitreous hemorrhage was evacuated, the hyaloid elevated, the periphery examined with an excellent widefield view without scleral depression, an air-fluid exchange performed, and the air exchanged for silicone oil. "
01/01/2018 - "Among these nine patients, six eyes were observed to have multiple silicone oil granules in the supraciliary cavity, three exhibited gaps of pars plana below the scleral incision site, and two had vitreous hemorrhage. "
06/01/2014 - "In this cohort, two had no light perception before surgery, another two had light perception, and one had hand motion perception as well as vitreous hemorrhage that had been plugged with silicone oil in other hospital. "

09/01/2012 - "As the dense vitreous hemorrhage was gradually cleared during the vitrectomy, a choroidal mass was discovered and the vitreous fluid was procured for rapid cytologic diagnosis. "
10/01/2010 - "Our findings illustrate the potential dangers of a conservative approach to vitreous hemorrhage and show that early vitrectomy has good outcome with acceptable complication rates. "
06/01/2010 - "Vitrectomy is beneficial for improving visual function in select cases of breakthrough vitreous hemorrhage."
04/01/2010 - "Residual vitreous cortex removal may be beneficial in reducing recurrence of postoperative vitreous hemorrhage following diabetic vitrectomy. "
01/01/2000 - "Vitrectomy for vitreous hemorrhage in Terson syndrome is a safe and effective procedure, offering a rapid and prolonged improvement in vision. "

12/01/1984 - "Follow-up of patients enrolled in a randomized prospective trial of feeder vessel photocoagulation for proliferative sickle cell retinopathy has shown that photocoagulation is effective in preventing vitreous hemorrhage and visual loss from vitreous hemorrhage. "
09/01/2019 - "He received panretinal photocoagulation, which improved the vision in the right eye and vitreous hemorrhage in the left eye. "
06/01/1984 - "After panretinal photocoagulation, the intravitreal ciliary body neovascularization regressed, the vitreous hemorrhage cleared, and the patient's visual acuity was 20/30. "
03/01/2013 - "Study eyes had vitreous hemorrhage from PDR precluding panretinal photocoagulation completion. "
07/01/2012 - "According to our study, the technique of choice for the treatment of recurrent vitreous hemorrhage secondary to PPV for PDR is endodiathermy of sclerotomy site fibrovascularization and adjuvant photocoagulation of the peripheral retina to the pars plana. "

03/01/2013 - "Intravitreal injection of saline has been shown potentially to lead to improved visual acuity compared with observation alone in eyes with vitreous hemorrhage. "
08/01/2001 - "On the basis of the results of this study, our conclusion is that volume homeostatic vitreous cavity lavage, combined with intravitreal injection of t-PA, is an excellent method for treatment of postvitrectomy diabetic vitreous hemorrhage but, in cases of PDVH with iris rubeosis, the advantage of this procedure is uncertain."
12/01/2020 - "WHY SHOULD AN EMERGENCY PHYSICIAN BE AWARE OF THIS?: Emergency physicians should have a high level of suspicion for AACG in patients who are diagnosed with a vitreous hemorrhage after intravitreal injection and should immediately measure IOP for elevation upon presentation to the ED."
01/01/2015 - "Dramatic resolution of vitreous hemorrhage after an intravitreal injection of dobesilate."
01/01/2014 - "Intravitreal injections of recombinant prourokinase led to more considerable gain of visual acuity and decrease of vitreous hemorrhage index in the first 24 hours in comparison with other treatment schemes. "

06/01/2014 - "In the ongoing Indian Twin Cities ROP study database, consecutive cases with isolated late vitreous hemorrhage at least one year after laser-regressed disease were analyzed retrospectively. "
04/01/2020 - "There was 1 case of vitreous hemorrhage in the laser group and no case of rubeosis iridis over time. "
01/01/2018 - "During the 9-month follow-up, one eye of the STM group progressed to vitreous hemorrhage at the month 6 follow-up and required rescue conventional laser. "
04/01/2017 - "After the laser treatment, the visual acuity completely recovered and there was no recurrence of vitreous hemorrhage. "
06/01/2014 - "Anterior hyaloidal fibrovascular proliferation is an unreported and rare cause of vitreous hemorrhage, appearing years after laser-regressed ROP. "

07/01/1981 - "Small-group studies examined traction detachment and vitreous hemorrhage in relation to visual prognosis and postmortem data related to age at death and "final vision"."
10/01/2022 - "Review of surgical cases with cutter-associated traction from chronic vitreous hemorrhage (CATCH). "
03/01/2016 - "Indications for treatment included active ROP with the fellow eye being treated for type 1 ROP (2 eyes, 15.4%); concerning structural changes (9 eyes, 69.2%), including tangential traction with temporal vessel straightening concerning for macular dragging (8 eyes, 61.5%) and thick stage 3 membranes with anteroposterior traction concerning for progression to stage 4 ROP (3 eyes, 23.1%); persistent ROP at an advanced postmenstrual age (4 eyes, 30.8%); and/or vitreous hemorrhage (3 eyes, 23.1%). "
09/01/2014 - "Three eyes exhibited optic-disc dragging; two eyes progressed to Stage 4a ROP; two eyes presented with macular traction, without any detachment; and one eye developed a vitreous hemorrhage, which resolved spontaneously. "
09/01/2007 - "When the posterior hyaloid exerts traction, the edges of the neovascular complex are pulled forward, resulting in vitreous hemorrhage. "